Pharmacovigilance: A Practical Approach
Editat de Thao Doan, Fabio Lievano, Linda Scarazzini, Charles Schubert, Barbara Hendricksonen Limba Engleză Paperback – 28 mar 2025
Written by multidisciplinary experts in the fields of pharmaceutical and patient safety, Pharmacovigilance: A Practical Approach, Second Edition, provides a succinct, easy-to-digest overview of an increasingly critical area of medical safety. From cover to cover, this concise resource offers essential information for physicians and other health care professionals, clinical researchers, and regulators who need a comprehensive, up-to-date source of information on the principles and practice of pharmacovigilance.
Preț: 529.77 lei
Preț vechi: 753.31 lei
-30%
Puncte Express: 795
Carte disponibilă
Livrare economică 15-29 iunie
Livrare express 06-12 iunie pentru 222.53 lei
Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
Specificații
ISBN-13: 9780443118814
ISBN-10: 0443118817
Pagini: 260
Dimensiuni: 191 x 235 x 12 mm
Greutate: 0.46 kg
Ediția:2nd edition
Editura: Elsevier
ISBN-10: 0443118817
Pagini: 260
Dimensiuni: 191 x 235 x 12 mm
Greutate: 0.46 kg
Ediția:2nd edition
Editura: Elsevier
V-ar putea interesa
-
Principles and Practice of Clinical ResearchJohn I. Gallin-9%Preț: 621.18 lei682.62 lei -
Pharmaceutical MedicinePhil Ambery-5%Preț: 329.12 lei346.44 lei -
Oxford Handbook of Practical Drug TherapyDuncan Richards-19%Preț: 250.16 lei307.81 lei -
Brody's Human PharmacologyLynn Wecker-5%Preț: 545.76 lei574.49 lei -
Pharmacovigilance: A Practical ApproachThao Doan-5%Preț: 633.23 lei666.57 lei -
-33%Preț: 241.84 lei361.50 lei -
Oh's Intensive Care ManualJonathan M. Handy-30%Preț: 666.61 lei956.17 leiRecomandat -
Kumar and Clark's Clinical MedicineDavid Randall-27%Preț: 470.33 lei648.45 leiRecomandat -
Smith and Aitkenhead's Textbook of AnaesthesiaJonathan Thompson-30%Preț: 614.62 lei875.00 lei -
Saunders Nursing Drug Handbook 2026Robert Kizior-5%Preț: 323.42 lei340.45 lei -
Dale's Pharmacology CondensedClive P. Page-30%Preț: 214.10 lei307.49 lei -
-11%Preț: 311.10 lei348.01 lei -
Good Pharmacovigilance Practice GuideGreat Britain: Medicines and Healthcare Products Regulatory Agency-15%Preț: 282.31 lei331.38 lei -
Clinical Pharmacology and TherapeuticsGerard A. Mckay-5%Preț: 304.66 lei320.70 lei -
Textbook of PharmacoepidemiologyBrian L Strom-5%Preț: 588.58 lei619.56 lei -
Pharmacology and Therapeutics: Principles to PracticeScott A. Waldman-27%Preț: 755.28 lei1027.77 lei -
Introduction to the Pharmaceutical Sciences: An Integrated ApproachNita K. Pandit PhD-23%Preț: 561.69 lei727.26 lei -
Pharmacovigilance: Critique and Ways ForwardI. Ralph Edwards-5%Preț: 695.30 lei731.90 lei -
Pharmacovigilance EssentialsMukesh Nandave-5%Preț: 1139.91 lei1199.91 lei
Cuprins
SECTION 1 THE REGULATORY ENVIRONMENT AND THE PHARMACOVIGILANCE QUALITY SYSTEM
1. Does Regulation Drive Science or Does Science Drive Regulation?
SECTION 2 PRECLINICAL SAFETY ASSESSMENT
2. Absorption, Distribution, Metabolism and Excretion, Pharmacokinetics, and Safety Pharmacology
3. Preclinical Safety Assessment : General and Genetic Toxicology
4. Pharmacogenetics
SECTION 3 FIRST-IN-HUMAN TRIALS
5. Safety Planning for First-in-Human Trials
6. Pharmacokinetic and Pharmacodynamic Considerations in Safety Evaluation
SECTION 4 SAFETY ASSESSMENT IN CLINICAL TRIALS
7. Safety Monitoring in Clinical Trials
8. Introduction to Quantitative Methods and Visual Analytics in Drug Safety Data in Clinical Trials
9. Product Aggregate Safety Assessment
10. Data Monitoring Committees
SECTION 5 SIGNAL AND RISK MANAGEMENT
11. Methods of Signal Detection and Signal Management
12. Causality Assessment
13. Examples of Adverse Drug Reactions: Drug-Induced Liver Injury, Renal, Skin, Immune-Mediated Events, and Major Adverse Cardiac Events
14. Internal Safety Advisory Groups
15. Benefit-Risk Management
SECTION 6 ROLE OF EPIDEMIOLOGY AND REALWORLD EVIDENCE
16. Role of Epidemiology and Pharmacoepidemiology in the Biopharmaceutical Industry
17. Real-World Pharmacoepidemiology Studies
SECTION 7 SPECIAL POPULATIONS AND SPECIAL TOPICS
18. Pharmacovigilance in Pregnancy
19. Pharmacovigilance in Pediatrics
20. Pharmacovigilance in the Elderly
21. Vaccine Pharmacovigilance
22. Application of Human Factors and Health Literacy in Pharmacovigilance
23. Medical Device Safety Oversight and Surveillance
SECTION 8 THE NEXT FRONTIER
24. Information Technology in Pharmacovigilance: Current State and Future Directions
25. The Future of Pharmacovigilance
1. Does Regulation Drive Science or Does Science Drive Regulation?
SECTION 2 PRECLINICAL SAFETY ASSESSMENT
2. Absorption, Distribution, Metabolism and Excretion, Pharmacokinetics, and Safety Pharmacology
3. Preclinical Safety Assessment : General and Genetic Toxicology
4. Pharmacogenetics
SECTION 3 FIRST-IN-HUMAN TRIALS
5. Safety Planning for First-in-Human Trials
6. Pharmacokinetic and Pharmacodynamic Considerations in Safety Evaluation
SECTION 4 SAFETY ASSESSMENT IN CLINICAL TRIALS
7. Safety Monitoring in Clinical Trials
8. Introduction to Quantitative Methods and Visual Analytics in Drug Safety Data in Clinical Trials
9. Product Aggregate Safety Assessment
10. Data Monitoring Committees
SECTION 5 SIGNAL AND RISK MANAGEMENT
11. Methods of Signal Detection and Signal Management
12. Causality Assessment
13. Examples of Adverse Drug Reactions: Drug-Induced Liver Injury, Renal, Skin, Immune-Mediated Events, and Major Adverse Cardiac Events
14. Internal Safety Advisory Groups
15. Benefit-Risk Management
SECTION 6 ROLE OF EPIDEMIOLOGY AND REALWORLD EVIDENCE
16. Role of Epidemiology and Pharmacoepidemiology in the Biopharmaceutical Industry
17. Real-World Pharmacoepidemiology Studies
SECTION 7 SPECIAL POPULATIONS AND SPECIAL TOPICS
18. Pharmacovigilance in Pregnancy
19. Pharmacovigilance in Pediatrics
20. Pharmacovigilance in the Elderly
21. Vaccine Pharmacovigilance
22. Application of Human Factors and Health Literacy in Pharmacovigilance
23. Medical Device Safety Oversight and Surveillance
SECTION 8 THE NEXT FRONTIER
24. Information Technology in Pharmacovigilance: Current State and Future Directions
25. The Future of Pharmacovigilance